Zimmer Suspends Distribution From Puerto Rico Following FDA Warning Letter

Zimmer has temporarily suspended distribution of its Trilogy acetabular hip devices from its Puerto Rico facility following an FDA warning letter regarding its manufacturing practices, according to a Mass Device report.

Advertisement

According to the letter, the company lacked a testing protocol to ensure all devices met pre-determined design specifications and failed to validate the effect of manufacturing operations that incorporate metallic spikes into Trilogy devices.

As a result, the Puerto Rico facility has been temporarily closed as Zimmer works to implement the FDA-mandated processes.

More Articles on Orthopedic Devices:

8 New Orthopedic & Spine Device Launches

Mazor Robotics Finalizes Financing Agreement for Up To $15M

Spinal Elements to Launch Hero Allograft

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.